Exagen Inc. to Participate in Upcoming Investor Conference

Rhea-AI Summary

Exagen (Nasdaq:XGN) announced that its management will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on August 11, 2026. The company will host a Fireside Chat at 8:30 a.m. ET, with live and archived webcasts available on its investor relations website.

News Market Reaction – XGN

+1.14%

7 alerts

+1.14% Session close to close

+11.0% Peak Tracked

-2.4% Trough Tracked

$111.08M Market Cap

0.2x Rel. Volume

In the Jul 28 session, XGN gained 1.14%, reflecting a mild positive market reaction. Argus tracked a peak move of +11.0% during that session. Argus tracked a trough of -2.4% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CARLSBAD, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor conference:

Canaccord Genuity 46^th Annual Growth Conference – Boston, MA
Date: August 11, 2026
Fireside Chat at 8:30am ET
A live and archived webcast of the Fireside Chat will be available on Exagen’s Investor Relations website at investors.exagen.com.

About Exagen Inc.
Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen’s mission is to provide clarity in autoimmune disease decision-making and improve clinical outcomes through its innovative testing portfolio. The company’s flagship product, AVISE® CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sjögren’s disease earlier and with greater accuracy. Exagen’s CLIA-certified, CAP-accredited laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.

For more information, visit Exagen.com or follow Exagen on LinkedIn.

Investors:
Tina Jacobsen, CFA
IR@exagen.com

FAQ

When will Exagen (XGN) present at the Canaccord Genuity 46th Annual Growth Conference?

Exagen will present at the Canaccord Genuity 46th Annual Growth Conference on August 11, 2026. According to Exagen, management will participate in a scheduled fireside chat during the event in Boston, Massachusetts.

What time is Exagen's (XGN) fireside chat at the Canaccord Genuity 2026 conference?

Exagen's fireside chat is scheduled for 8:30 a.m. ET on August 11, 2026. According to Exagen, investors can access the live session and a replay through the company’s investor relations website.

How can investors access the Exagen (XGN) webcast for the August 11, 2026 fireside chat?

Investors can access a live and archived webcast of Exagen's fireside chat on the company’s investor relations website at investors.exagen.com. According to Exagen, both real-time and replay viewing options will be provided online.

Where is the Canaccord Genuity 46th Annual Growth Conference featuring Exagen (XGN) being held?

The Canaccord Genuity 46th Annual Growth Conference featuring Exagen is being held in Boston, Massachusetts. According to Exagen, its management team will join the event and host a fireside chat for investors.

Is a replay available for Exagen's (XGN) fireside chat at the August 2026 Canaccord conference?

Yes, a replay of Exagen's fireside chat will be available as an archived webcast on investors.exagen.com. According to Exagen, both the live presentation and its archive can be accessed through the investor relations site.